Provided by Tiger Trade Technology Pte. Ltd.

DIMERIX LTD

0.515
-0.015-2.83%
Volume:232.12K
Turnover:121.32K
Market Cap:309.20M
PE:-21.78
High:0.535
Open:0.535
Low:0.515
Close:0.530
52wk High:0.785
52wk Low:0.340
Shares:600.40M
Float Shares:467.70M
Volume Ratio:0.56
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.024
EPS(LYR):-0.024
ROE:-83.97%
ROA:-32.13%
PB:23.11
PE(LYR):-21.78

Loading ...

Company Profile

Company Name:
DIMERIX LTD
Exchange:
ASX
Establishment Date:
- -
Employees:
- -
Office Location:
425 Smith Street,Fitzroy,Victoria,Australia
Zip Code:
3065
Fax:
61 8 9388 8256
Introduction:
Dimerix Limited, a clinical stage biotechnology company, develops and commercializes new therapies in the area of unmet medical needs. Its lead product candidate is DMX-200, which is in Phase II clinical trial for the treatment of diabetic kidney diseases and focal segmental glomerulosclerosis. The company is headquartered in Fitzroy, Australia.